157 related articles for article (PubMed ID: 36958250)
1. Low level of antioxidant capacity biomarkers but not target overexpression predicts vulnerability to ROS-inducing drugs.
Samarin J; Fabrowski P; Kurilov R; Nuskova H; Hummel-Eisenbeiss J; Pink H; Li N; Weru V; Alborzinia H; Yildiz U; Grob L; Taubert M; Czech M; Morgen M; Brandstädter C; Becker K; Mao L; Jayavelu AK; Goncalves A; Uhrig U; Seiler J; Lyu Y; Diederichs S; Klingmüller U; Muckenthaler M; Kopp-Schneider A; Teleman A; Miller AK; Gunkel N
Redox Biol; 2023 Jun; 62():102639. PubMed ID: 36958250
[TBL] [Abstract][Full Text] [Related]
2. Hepatic AMPK signaling dynamic activation in response to REDOX balance are sentinel biomarkers of exercise and antioxidant intervention to improve blood glucose control.
Wu M; Zhao A; Yan X; Gao H; Zhang C; Liu X; Luo Q; Xie F; Liu S; Shi D
Elife; 2022 Sep; 11():. PubMed ID: 36155132
[TBL] [Abstract][Full Text] [Related]
3. Intracellular levels of reactive oxygen species correlate with ABT-263 sensitivity in non-small-cell lung cancer cells.
Ohgino K; Terai H; Yasuda H; Nukaga S; Hamamoto J; Tani T; Kuroda A; Arai D; Ishioka K; Masuzawa K; Ikemura S; Kawada I; Naoki K; Fukunaga K; Soejima K
Cancer Sci; 2020 Oct; 111(10):3793-3801. PubMed ID: 32687646
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents.
Sies H; Jones DP
Nat Rev Mol Cell Biol; 2020 Jul; 21(7):363-383. PubMed ID: 32231263
[TBL] [Abstract][Full Text] [Related]
5. Experimental therapeutics: targeting the redox Achilles heel of cancer.
Cabello CM; Bair WB; Wondrak GT
Curr Opin Investig Drugs; 2007 Dec; 8(12):1022-37. PubMed ID: 18058573
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress associated metabolic adaptations regulate radioresistance in human lung cancer cells.
Singh B; Patwardhan RS; Jayakumar S; Sharma D; Sandur SK
J Photochem Photobiol B; 2020 Dec; 213():112080. PubMed ID: 33232882
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy-mediated redox homeostasis-controllable nanomedicine for enhanced ferroptosis sensitivity in tumor therapy.
Lin Y; Chen X; Yu C; Xu G; Nie X; Cheng Y; Luan Y; Song Q
Acta Biomater; 2023 Mar; 159():300-311. PubMed ID: 36642338
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of a novel STAT3 inhibitor and redox modulator in non-small cell lung cancer cells.
Liu X; Guo W; Wu S; Wang L; Wang J; Dai B; Kim ES; Heymach JV; Wang M; Girard L; Minna J; Roth JA; Swisher SG; Fang B
Biochem Pharmacol; 2012 May; 83(10):1456-64. PubMed ID: 22387047
[TBL] [Abstract][Full Text] [Related]
9. Extract of Murraya koenigii selectively causes genomic instability by altering redox-status via targeting PI3K/AKT/Nrf2/caspase-3 signaling pathway in human non-small cell lung cancer.
Mondal P; Natesh J; Penta D; Meeran SM
Phytomedicine; 2022 Sep; 104():154272. PubMed ID: 35728387
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic activities of brusatol in human non-small cell lung cancer cells: Involvement of ROS-mediated mitochondrial-dependent pathway and inhibition of Nrf2-mediated antioxidant response.
Xie J; Lai Z; Zheng X; Liao H; Xian Y; Li Q; Wu J; Ip S; Xie Y; Chen J; Su Z; Lin Z; Yang X
Toxicology; 2021 Mar; 451():152680. PubMed ID: 33465425
[TBL] [Abstract][Full Text] [Related]
11. Effective Killing of Cancer Cells Through ROS-Mediated Mechanisms by AMRI-59 Targeting Peroxiredoxin I.
Yang YJ; Baek JY; Goo J; Shin Y; Park JK; Jang JY; Wang SB; Jeong W; Lee HJ; Um HD; Lee SK; Choi Y; Rhee SG; Chang TS
Antioxid Redox Signal; 2016 Mar; 24(8):453-69. PubMed ID: 26528922
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
13. A reactive oxygen species-replenishing coordination polymer nanomedicine disrupts redox homeostasis and induces concurrent apoptosis-ferroptosis for combinational cancer therapy.
Zhang Z; Pan Y; Cun JE; Li J; Guo Z; Pan Q; Gao W; Pu Y; Luo K; He B
Acta Biomater; 2022 Oct; 151():480-490. PubMed ID: 35926781
[TBL] [Abstract][Full Text] [Related]
14. The Future Challenge of Reactive Oxygen Species (ROS) in Hypertension: From Bench to Bed Side.
Togliatto G; Lombardo G; Brizzi MF
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28914782
[TBL] [Abstract][Full Text] [Related]
15. Lysine oxidase exposes a dependency on the thioredoxin antioxidant pathway in triple-negative breast cancer cells.
Chepikova OE; Malin D; Strekalova E; Lukasheva EV; Zamyatnin AA; Cryns VL
Breast Cancer Res Treat; 2020 Oct; 183(3):549-564. PubMed ID: 32696316
[TBL] [Abstract][Full Text] [Related]
16. Targeting Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer by Inducing Epidermal Growth Factor Receptor Degradation via Methionine 790 Oxidation.
Leung EL; Fan XX; Wong MP; Jiang ZH; Liu ZQ; Yao XJ; Lu LL; Zhou YL; Yau LF; Tin VP; Liu L
Antioxid Redox Signal; 2016 Feb; 24(5):263-79. PubMed ID: 26528827
[TBL] [Abstract][Full Text] [Related]
17. Influence of vitamin C and vitamin E on redox signaling: Implications for exercise adaptations.
Cobley JN; McHardy H; Morton JP; Nikolaidis MG; Close GL
Free Radic Biol Med; 2015 Jul; 84():65-76. PubMed ID: 25841784
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress and therapeutic opportunities: focus on the Ewing's sarcoma family of tumors.
Smith DG; Magwere T; Burchill SA
Expert Rev Anticancer Ther; 2011 Feb; 11(2):229-49. PubMed ID: 21342042
[TBL] [Abstract][Full Text] [Related]
19. Oxidative metabolism, ROS and NO under oxygen deprivation.
Blokhina O; Fagerstedt KV
Plant Physiol Biochem; 2010 May; 48(5):359-73. PubMed ID: 20303775
[TBL] [Abstract][Full Text] [Related]
20. Cellular redox pathways as a therapeutic target in the treatment of cancer.
Montero AJ; Jassem J
Drugs; 2011 Jul; 71(11):1385-96. PubMed ID: 21812504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
